risperidone has been researched along with Cirrhosis, Liver in 2 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heykants, J | 2 |
| Huang, ML | 1 |
| Mannens, G | 2 |
| Meuldermans, W | 1 |
| Snoeck, E | 2 |
| Van Beijsterveldt, L | 1 |
| Van Peer, A | 2 |
| Woestenborghs, R | 2 |
| Sack, M | 1 |
| Horton, M | 1 |
| Meibach, R | 1 |
1 trial available for risperidone and Cirrhosis, Liver
| Article | Year |
|---|---|
Influence of age, renal and liver impairment on the pharmacokinetics of risperidone in man.
Topics: Adult; Age Factors; Aged; Antipsychotic Agents; Blood Proteins; Female; Half-Life; Humans; Kidney Fa | 1995 |
1 other study available for risperidone and Cirrhosis, Liver
| Article | Year |
|---|---|
The pharmacokinetics of risperidone in humans: a summary.
Topics: Aged; Animals; Antipsychotic Agents; Biotransformation; Dogs; Half-Life; Humans; Isoxazoles; Liver C | 1994 |